We use cookies to enhance the usability of our website. If you continue, we'll assume that you are happy to receive all cookies. More information. Don't show this again.
Cancer cells showed weak to moderate nuclear staining. Gliomas along with occasional cases of breast and urothelial cancers showed strong positivity.
GENE INFORMATION
Gene name
H2AFY (HGNC Symbol)
Synonyms
macroH2A1.2
Description
H2A histone family, member Y (HGNC Symbol)
Entrez gene summary
Histones are basic nuclear proteins that are responsible for the nucleosome structure of the chromosomal fiber in eukaryotes. Nucleosomes consist of approximately 146 bp of DNA wrapped around a histone octamer composed of pairs of each of the four core histones (H2A, H2B, H3, and H4). The chromatin fiber is further compacted through the interaction of a linker histone, H1, with the DNA between the nucleosomes to form higher order chromatin structures. This gene encodes a replication-independent histone that is a member of the histone H2A family. It replaces conventional H2A histones in a subset of nucleosomes where it represses transcription and participates in stable X chromosome inactivation. Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Oct 2015]
SPOCTOPUS predicted membrane proteins Predicted intracellular proteins Plasma proteins Protein evidence (Kim et al 2014) Protein evidence (Ezkurdia et al 2014)
Show all
GO:0000122 [negative regulation of transcription from RNA polymerase II promoter] GO:0000182 [rDNA binding] GO:0000228 [nuclear chromosome] GO:0000784 [nuclear chromosome, telomeric region] GO:0000785 [chromatin] GO:0000786 [nucleosome] GO:0000790 [nuclear chromatin] GO:0000793 [condensed chromosome] GO:0000977 [RNA polymerase II regulatory region sequence-specific DNA binding] GO:0000979 [RNA polymerase II core promoter sequence-specific DNA binding] GO:0001046 [core promoter sequence-specific DNA binding] GO:0001739 [sex chromatin] GO:0001740 [Barr body] GO:0003677 [DNA binding] GO:0003682 [chromatin binding] GO:0005515 [protein binding] GO:0005634 [nucleus] GO:0005654 [nucleoplasm] GO:0005721 [pericentric heterochromatin] GO:0005730 [nucleolus] GO:0006334 [nucleosome assembly] GO:0007549 [dosage compensation] GO:0010385 [double-stranded methylated DNA binding] GO:0016568 [chromatin modification] GO:0019216 [regulation of lipid metabolic process] GO:0019901 [protein kinase binding] GO:0030291 [protein serine/threonine kinase inhibitor activity] GO:0031490 [chromatin DNA binding] GO:0031492 [nucleosomal DNA binding] GO:0033128 [negative regulation of histone phosphorylation] GO:0035098 [ESC/E(Z) complex] GO:0040029 [regulation of gene expression, epigenetic] GO:0044212 [transcription regulatory region DNA binding] GO:0045618 [positive regulation of keratinocyte differentiation] GO:0045814 [negative regulation of gene expression, epigenetic] GO:0045815 [positive regulation of gene expression, epigenetic] GO:0046982 [protein heterodimerization activity] GO:0051572 [negative regulation of histone H3-K4 methylation] GO:0061086 [negative regulation of histone H3-K27 methylation] GO:0070062 [extracellular exosome] GO:0071169 [establishment of protein localization to chromatin] GO:0071901 [negative regulation of protein serine/threonine kinase activity] GO:1901837 [negative regulation of transcription of nuclear large rRNA transcript from RNA polymerase I promoter] GO:1902750 [negative regulation of cell cycle G2/M phase transition]
SPOCTOPUS predicted membrane proteins Predicted intracellular proteins Plasma proteins Protein evidence (Kim et al 2014) Protein evidence (Ezkurdia et al 2014)
Show all
GO:0000122 [negative regulation of transcription from RNA polymerase II promoter] GO:0000182 [rDNA binding] GO:0000228 [nuclear chromosome] GO:0000784 [nuclear chromosome, telomeric region] GO:0000786 [nucleosome] GO:0000790 [nuclear chromatin] GO:0000977 [RNA polymerase II regulatory region sequence-specific DNA binding] GO:0000979 [RNA polymerase II core promoter sequence-specific DNA binding] GO:0001046 [core promoter sequence-specific DNA binding] GO:0001739 [sex chromatin] GO:0001740 [Barr body] GO:0003677 [DNA binding] GO:0005515 [protein binding] GO:0005634 [nucleus] GO:0005654 [nucleoplasm] GO:0005721 [pericentric heterochromatin] GO:0005730 [nucleolus] GO:0006334 [nucleosome assembly] GO:0007549 [dosage compensation] GO:0010385 [double-stranded methylated DNA binding] GO:0016568 [chromatin modification] GO:0019216 [regulation of lipid metabolic process] GO:0019901 [protein kinase binding] GO:0030291 [protein serine/threonine kinase inhibitor activity] GO:0031490 [chromatin DNA binding] GO:0031492 [nucleosomal DNA binding] GO:0033128 [negative regulation of histone phosphorylation] GO:0035098 [ESC/E(Z) complex] GO:0040029 [regulation of gene expression, epigenetic] GO:0044212 [transcription regulatory region DNA binding] GO:0045618 [positive regulation of keratinocyte differentiation] GO:0045814 [negative regulation of gene expression, epigenetic] GO:0045815 [positive regulation of gene expression, epigenetic] GO:0046982 [protein heterodimerization activity] GO:0051572 [negative regulation of histone H3-K4 methylation] GO:0061086 [negative regulation of histone H3-K27 methylation] GO:0070062 [extracellular exosome] GO:0071169 [establishment of protein localization to chromatin] GO:0071901 [negative regulation of protein serine/threonine kinase activity] GO:1901837 [negative regulation of transcription of nuclear large rRNA transcript from RNA polymerase I promoter] GO:1902750 [negative regulation of cell cycle G2/M phase transition]
SPOCTOPUS predicted membrane proteins Predicted intracellular proteins Plasma proteins Protein evidence (Kim et al 2014) Protein evidence (Ezkurdia et al 2014)
Show all
GO:0000122 [negative regulation of transcription from RNA polymerase II promoter] GO:0000182 [rDNA binding] GO:0000228 [nuclear chromosome] GO:0000784 [nuclear chromosome, telomeric region] GO:0000786 [nucleosome] GO:0000790 [nuclear chromatin] GO:0000977 [RNA polymerase II regulatory region sequence-specific DNA binding] GO:0000979 [RNA polymerase II core promoter sequence-specific DNA binding] GO:0001046 [core promoter sequence-specific DNA binding] GO:0001739 [sex chromatin] GO:0001740 [Barr body] GO:0003677 [DNA binding] GO:0005515 [protein binding] GO:0005634 [nucleus] GO:0005654 [nucleoplasm] GO:0005721 [pericentric heterochromatin] GO:0005730 [nucleolus] GO:0006334 [nucleosome assembly] GO:0007549 [dosage compensation] GO:0010385 [double-stranded methylated DNA binding] GO:0016568 [chromatin modification] GO:0019216 [regulation of lipid metabolic process] GO:0019901 [protein kinase binding] GO:0030291 [protein serine/threonine kinase inhibitor activity] GO:0031490 [chromatin DNA binding] GO:0031492 [nucleosomal DNA binding] GO:0033128 [negative regulation of histone phosphorylation] GO:0035098 [ESC/E(Z) complex] GO:0040029 [regulation of gene expression, epigenetic] GO:0044212 [transcription regulatory region DNA binding] GO:0045618 [positive regulation of keratinocyte differentiation] GO:0045814 [negative regulation of gene expression, epigenetic] GO:0045815 [positive regulation of gene expression, epigenetic] GO:0046982 [protein heterodimerization activity] GO:0051572 [negative regulation of histone H3-K4 methylation] GO:0061086 [negative regulation of histone H3-K27 methylation] GO:0070062 [extracellular exosome] GO:0071169 [establishment of protein localization to chromatin] GO:0071901 [negative regulation of protein serine/threonine kinase activity] GO:1901837 [negative regulation of transcription of nuclear large rRNA transcript from RNA polymerase I promoter] GO:1902750 [negative regulation of cell cycle G2/M phase transition]